Israel Englander’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-120,000
Closed -$325K 5945
2025
Q4
$325K Buy
+120,000
New +$394K ﹤0.01% 5215
2024
Q4
Sell
-100,000
Closed -$694K 6127
2024
Q3
$694K Buy
+100,000
New +$785K ﹤0.01% 4566
2024
Q2
Sell
-30,000
Closed -$213K 6106
2024
Q1
$213K Buy
+30,000
New +$198K ﹤0.01% 5342
2022
Q3
Sell
-29,400
Closed -$174K 7210
2022
Q2
$174K Buy
+29,400
New +$327K ﹤0.01% 5702
2022
Q1
Sell
-90,000
Closed -$2.94M 7096
2021
Q4
$2.94M Buy
90,000
+70,000
+350% +$2.82M ﹤0.01% 3400
2021
Q3
$820K Sell
20,000
-30,000
-60% -$1.09M ﹤0.01% 4888
2021
Q2
$1.8M Buy
+50,000
New +$1.85M ﹤0.01% 4084
2021
Q1
Sell
-10,900
Closed -$440K 6127
2020
Q4
$440K Buy
+10,900
New +$501K ﹤0.01% 4294

Other funds holding GDRX

Israel Englander's GDRX Position: Q2 2026 in Review

Israel Englander increased its GoodRx Holdings (GDRX) stake by 1,303% in Q2 2026, buying an estimated $842K and bringing the position to 356,654 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #4294.

Israel Englander first reported a position in GDRX in Q3 2020 and has held it in 21 quarters since. The position peaked at $32.2M in Q2 2024. 159 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • Israel Englander held 356,654 shares of GoodRx Holdings worth $1.03M as of Q2 2026.
  • Israel Englander bought 331,227 GoodRx Holdings shares in Q2 2026, an estimated $842K.
  • GoodRx Holdings made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4294 holding.
  • Israel Englander first reported a position in GoodRx Holdings in Q3 2020 and has held it in 21 quarters since.
  • Israel Englander's GoodRx Holdings position peaked at $32.2M in Q2 2024.
  • 159 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.